技术文章

Classification of Chemokines, Receptor Signaling, and Regulatory Mechanisms of Immune Cell Migration

Chemokines are a class of small secreted proteins that regulate directional cell migration. They primarily establish spatial signals through chemokine receptors, cell-surface glycosaminoglycans, and cell-adhesion systems, thereby guiding neutrophils, monocytes, T cells, NK cells, and other cells into specific tissues. Chemokine networks participate in immune surveillance, inflammatory-cell recruitment, hematopoietic-cell homing, tissue repair, and formation of the tumor microenvironment, and their effects are jointly influenced by ligand concentration, receptor expression, spatial gradients, protein-processing status, and the responding cell type.

 

Keywords: chemokines; CXC chemokines; CC chemokines; CXCR; CCR; cell migration; chemotactic gradient; immune-cell recruitment; inflammatory response

 

1 Basic Characteristics of Chemokines

1.1 Basic Functions of Chemokines

(1) Directional Cell Migration

Chemokines can form concentration gradients in tissue fluid, on the vascular endothelial surface, or within the extracellular matrix. After cells expressing the corresponding receptors sense the gradient, they establish front-rear polarity and migrate toward increasing chemokine concentrations, accompanied by integrin activation, cell adhesion, and actin remodeling.

(2) Inflammatory and Homeostatic Regulation

Inflammatory chemokines are usually rapidly expressed after infection or tissue injury and are responsible for recruiting inflammatory cells, whereas homeostatic chemokines are constitutively expressed in specific tissues and participate in hematopoietic-cell homing, lymphocyte positioning, tissue residency, and immune surveillance.

(3) Ligand-Receptor Networks

Chemokine networks exhibit extensive cross-reactivity. The same chemokine may bind multiple receptors, and the same receptor may respond to multiple ligands. For example, CXCR2 recognizes multiple ELR-positive CXC chemokines, whereas CCL5 can act on CCR1, CCR3, and CCR5. Therefore, increased chemokine expression should be interpreted together with receptor expression and functional assays.

 

1.2 Structural Classification of Chemokines

(1) CXC Chemokines

In CXC chemokines, the two conserved cysteines near the amino terminus are separated by one amino acid. Some members contain an ELR motif composed of glutamic acid, leucine, and arginine before the first cysteine. ELR-positive members mainly participate in neutrophil recruitment, whereas ELR-negative members are more involved in lymphocyte migration, vascular regulation, and tissue positioning.

(2) CC Chemokines

In CC chemokines, the two conserved cysteines near the amino terminus are adjacent to each other. These chemokines mainly regulate the migration of monocytes, T cells, eosinophils, and dendritic cells through CCR-family receptors.

(3) CX3C and XC Chemokines

In CX3C chemokines, the two amino-terminal conserved cysteines are separated by three amino acids, with CX3CL1 as the representative member. XC chemokines retain only the second and fourth of the four conserved cysteines found in other typical chemokine classes and therefore lack the first and third conserved cysteines; representative members include XCL1 and XCL2.

 

 

Figure 1 Three-dimensional structure of chemokines

 

 

Figure 2 Conserved structural elements and disulfide bonding pattern of chemokines

 

Chemokine Category

Representative Members

Major Receptors or Functional Axes

Major Functions

ELR-positive CXC chemokines

CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8

CXCR1 and CXCR2

Neutrophil recruitment, degranulation, reactive oxygen species generation, and acute inflammation

ELR-negative and specialized CXC chemokines

CXCL4, CXCL9, CXCL10, and CXCL11

CXCR3-associated or glycosaminoglycan-dependent mechanisms

Recruitment of activated T cells and NK cells, vascular regulation, and inflammatory modulation

Tissue-positioning-associated CXC chemokines

CXCL12, CXCL16, and CXCL17

CXCR4, ACKR3, CXCR6, or receptors not yet clearly identified

Hematopoietic-cell homing, tissue residency, mucosal immunity, and cell adhesion

CC chemokines

CCL1, CCL3, CCL5, CCL8, CCL15, and CCL17

CCR1, CCR2, CCR3, CCR4, CCR5, CCR8, and others

Recruitment of monocytes and lymphocytes, chronic inflammation, and allergic responses

CX3C chemokines

CX3CL1

CX3CR1

Cell adhesion and chemotaxis

XC chemokines

XCL1 and XCL2

XCR1

Recruitment of cross-presenting dendritic cells

 

1.3 Chemokine Receptors

(1) Classical Chemokine Receptors

Classical chemokine receptors are seven-transmembrane G protein-coupled receptors and are divided into CXCR, CCR, CX3CR, and XCR families according to their ligand types. Different immune cells have distinct receptor-expression profiles. For example, CXCR2 mainly participates in neutrophil recruitment, CXCR3 is commonly expressed on activated T cells and NK cells, CXCR4 participates in hematopoietic-cell homing, and CCR4 is associated with the migration of certain Th2 cells and regulatory T cells.

(2) Atypical Chemokine Receptors

Atypical chemokine receptors such as ACKR1, ACKR2, ACKR3, and ACKR4 generally do not generate classical Gi protein-dependent chemotactic signaling. Instead, they regulate chemokine distribution within tissues through ligand uptake, transport, presentation, or clearance. ACKR3 can bind CXCL12 and regulate the signaling range of the CXCL12-CXCR4 axis.

(3) Species Differences

Chemokine networks exhibit marked species differences. Human CXCL8 is an important ligand for CXCR1 and CXCR2, whereas mice lack a direct homolog that fully corresponds to human CXCL8. Mouse studies commonly use CXCL1, CXCL2, or CXCL5 to analyze similar neutrophil-recruitment processes.

 

2 Major Functions of CXC Chemokines

2.1 ELR-Positive CXC Chemokines and Neutrophil Recruitment

(1) CXCL1, CXCL2, and CXCL3

CXCL1, CXCL2, and CXCL3 are also known as GROα, GROβ, and GROγ, respectively. They mainly promote the migration of neutrophils and certain myeloid cells through CXCR2 and participate in inflammatory-cell recruitment during infection, tissue injury, and within the tumor microenvironment.

(2) CXCL5 and CXCL6

CXCL5 mainly promotes neutrophil migration through CXCR2. CXCL6 can act on both CXCR1 and CXCR2, and its receptor-activating capacity may also be affected by amino-terminal proteolytic processing.

(3) CXCL7 and Its Processed Forms

CXCL7 is generated by processing the platelet precursor protein PPBP. PBP, CTAP-III, and NAP-2 represent different processed forms, among which NAP-2 has strong CXCR2 agonistic and neutrophil-chemotactic activity. Therefore, different CXCL7 protein forms should not be regarded as completely equivalent.

(4) CXCL8

CXCL8, also known as IL-8, promotes neutrophil migration, integrin activation, degranulation, and reactive oxygen species generation through CXCR1 and CXCR2. Animal-derived CXCL8 should preferentially be used with cells from the same species, and receptor-activating activity should be confirmed through functional assays.

 

2.2 CXCL4 and Platelet-Associated Inflammatory Regulation

(1) Source and Release

CXCL4, also known as platelet factor 4, is mainly stored in platelet α-granules and released after platelet activation. It participates in vascular injury, leukocyte recruitment, and regulation of thromboinflammation.

(2) Glycosaminoglycan Binding

CXCL4 has strong heparin- and glycosaminoglycan-binding capacity. Heparin and other negatively charged substances may alter its aggregation state, spatial distribution, and effective concentration. Therefore, the formation of protein complexes should be considered in experimental systems containing heparin.

(3) Regulation of Vascular and Myeloid Cells

CXCL4 can regulate endothelial-cell, monocyte, and macrophage functions. Its mechanism of action is strongly dependent on cell type and experimental conditions and cannot be determined solely from expression of a single receptor.

 

2.3 CXCL9, CXCL10, CXCL11, and CXCR3 Signaling

(1) Recruitment of CXCR3-Positive Cells

CXCL9, CXCL10, and CXCL11 are commonly induced by interferon signaling and mainly promote migration of activated T cells and NK cells into inflamed tissues through CXCR3, participating in antiviral immunity, Th1-type inflammation, and tumor immunity.

(2) Functional Differences Among Ligands

Although the three ligands share CXCR3, they are not identical in receptor binding, receptor internalization, β-arrestin recruitment, and signaling duration. Therefore, they should not be used interchangeably as completely equivalent stimuli.

 

2.4 CXCL12, CXCL16, and CXCL17

(1) CXCL12-CXCR4/ACKR3 Axis

CXCL12, also known as SDF-1, mainly acts on CXCR4 and can also bind ACKR3. It participates in hematopoietic stem-cell homing to the bone marrow, immune-cell migration, tissue repair, and tumor-cell dissemination.

(2) CXCL16-CXCR6 Axis

CXCL16 exists in both membrane-bound and soluble forms. Membrane-bound CXCL16 can participate in cell adhesion and lipid uptake, whereas soluble CXCL16 mainly promotes migration of activated T cells and NK cells through CXCR6. Soluble recombinant protein cannot completely substitute for the functions of membrane-bound CXCL16.

(3) CXCL17 and Its Receptor

CXCL17 is mainly expressed in certain mucosal tissues and can affect migration of monocytes and other myeloid cells. Its functional receptor has not yet been conclusively identified, so migration, dose-response, and functional-blockade results should serve as the primary evidence in related studies.

 

3 Major Functions of CC Chemokines

3.1 CCL1-CCR8 Signaling

(1) Receptor and Responding Cells

CCL1 mainly acts on CCR8 and can recruit certain CCR8-positive T cells, regulatory T cells, and myeloid cells. Mouse CCL1 is also known as TCA-3.

(2) Immunoregulatory Effects

The CCL1-CCR8 axis participates in Th2-type immunity, positioning of tissue-resident immune cells, and regulation of the tumor immune microenvironment. When CCL1 is used in migration assays, CCR8 surface expression and receptor-blocking results should be evaluated together.

 

3.2 CCL3 and CCL5

(1) CCL3-CCR1/CCR5 Axis

CCL3, also known as MIP-1α, mainly acts on CCR1 and CCR5 and can promote migration of monocytes, macrophages, T cells, and other inflammatory cells. It can also cooperate with other inflammatory mediators to amplify local cellular infiltration.

(2) Multireceptor Activity of CCL5

CCL5, also known as RANTES, can act on CCR1, CCR3, and CCR5 and participates in the migration of T cells, monocytes, and eosinophils. CCL5 also has strong glycosaminoglycan-binding and aggregation capacities, and its immobilized state and aggregation form may influence receptor activation.

 

3.3 CCL8, CCL15, and CCL17

(1) Multireceptor Characteristics of CCL8

CCL8, also known as MCP-2, can interact with receptors including CCR1, CCR2, CCR3, and CCR5. When studying CCL8 function, receptor expression and individual or combined receptor-blocking experiments should be used to analyze the contribution of different receptors.

(2) Processing Dependence of CCL15

CCL15, also known as MIP-5, is mainly associated with CCR1 and CCR3. Amino-terminal processing can alter its receptor activation and chemotactic capacity, so the effective concentrations of different protein forms may vary.

(3) CCL17-CCR4 Axis

CCL17, also known as TARC, is an important ligand for CCR4 and can recruit Th2 cells, certain regulatory T cells, and skin-homing T cells. It is commonly used in research on allergic inflammation, skin inflammation, and tumor immunity.

 

4 Chemokine Receptors and Cell-Migration Signaling

4.1 G Protein-Dependent Signaling

(1) Gi Protein Activation

Classical chemokine receptors are mainly coupled to Gi-family G proteins. After ligand binding, Gαi inhibits adenylyl cyclase, whereas Gβγ activates signaling molecules such as PLCβ and PI3K.

(2) PLCβ-Ca²⁺ Signaling

PLCβ promotes the breakdown of phosphatidylinositol bisphosphate to generate IP3 and DAG. IP3 promotes intracellular Ca²⁺ release, whereas DAG participates in protein kinase C activation. Ca²⁺ flux can be used to evaluate early receptor activation but cannot independently demonstrate directional cell migration.

(3) PI3K and Small GTPases

PI3K signaling becomes enriched at the leading edge of the cell and regulates actin polymerization, pseudopod formation, and contraction of the cell rear through small GTPases including Rac, Cdc42, and Rho, enabling migration along a chemokine gradient.

(4) Integrin Activation

Chemokine receptors can increase integrin affinity through inside-out signaling, allowing leukocytes to adhere firmly to the vascular endothelial surface and subsequently complete crawling and transendothelial migration.

 

4.2 Glycosaminoglycans and Chemotactic Gradients

(1) Immobilized Gradients

Chemokines can bind glycosaminoglycans such as heparan sulfate and chondroitin sulfate on endothelial-cell surfaces and in the extracellular matrix, thereby restricting free diffusion and forming immobilized gradients.

(2) Protein Aggregation State

Glycosaminoglycan binding may alter the monomeric, dimeric, and higher-order oligomeric states of chemokines. Therefore, total chemokine concentration is not equivalent to the free concentration available for direct receptor activation.

(3) Differences Among Experimental Models

Transwell assays mainly simulate soluble gradients, whereas endothelial-cell, three-dimensional matrix, and microfluidic models more closely resemble immobilized gradients in tissues. Migration results obtained from different models cannot be considered directly equivalent.

 

4.3 Receptor Desensitization and Internalization

(1) Receptor Desensitization

Sustained or high-concentration chemokine stimulation can induce receptor phosphorylation, β-arrestin recruitment, and receptor internalization, thereby reducing cellular responsiveness to subsequent stimulation.

(2) Bell-Shaped Dose-Response Curves

Chemokine concentrations that are too low cannot generate effective stimulation, whereas excessively high concentrations may cause receptor desensitization or disrupt the spatial gradient. Therefore, chemotaxis experiments commonly exhibit bell-shaped dose-response curves.

(3) Cross-Desensitization

Cross-desensitization may occur among different chemokine receptors. When multiple chemokines are used together, the resulting effects may be synergistic, competitive, or mutually inhibitory.

 

5 Experimental Detection and Interpretation of Chemokines

5.1 Cell-Migration Models

(1) Transwell Migration Assay

The Transwell assay places a chemokine in the lower chamber and measures the number of cells migrating through a porous membrane. It is suitable for concentration screening and comparison of multiple groups. Pore size, cell-seeding density, incubation time, and serum concentration should be controlled.

(2) Microfluidic Migration Assay

Microfluidic systems can establish stable and controllable chemotactic gradients and continuously record cell trajectories. Analysis of migration speed, directionality, and forward-migration index can distinguish directional chemotaxis from increased random motility.

(3) Three-Dimensional Matrix Models

Three-dimensional matrix models can be used to observe cell migration in a spatial environment, but the results are jointly affected by matrix pore size, stiffness, degradability, and chemokine adsorption.

(4) Distinguishing Chemotaxis From Chemokinesis

Chemotaxis is directional migration along a concentration gradient, whereas chemokinesis is an increase in random motility. Equal-concentration controls in the upper and lower chambers should be included to exclude effects caused by changes in cell survival, adhesion, or random movement.

 

5.2 Validation of Receptor Dependence

(1) Receptor-Expression Detection

Chemokine receptor expression can be analyzed by flow cytometry, immunofluorescence, Western blotting, or transcript detection. Among these methods, measurement of cell-surface receptor expression generally more closely reflects the actual response capacity of cells.

(2) Receptor Blockade and Genetic Intervention

Blocking antibodies, small-molecule antagonists, siRNA, or CRISPR knockout can be used to validate receptor dependence. For chemokines that bind multiple receptors, individual and combined receptor blockade should be performed.

(3) Validation of Ligands Sharing the Same Receptor

The common pathway used by CXCL1, CXCL2, CXCL3, and CXCL5 can be validated through CXCR2 blockade. When studying CXCL6 or CXCL8, the involvement of CXCR1 should also be evaluated according to the cell type.

 

5.3 Conditions for Using Recombinant Chemokines

(1) Species Matching

Human-, mouse-, porcine-, and rat-derived chemokines should preferably be used with cells from the same species. Before cross-species use, activity should be confirmed through migration, Ca²⁺-flux, or receptor-internalization assays.

(2) Mature Protein Forms

Amino-terminal processing of chemokines such as CXCL7 and CCL15 alters receptor-activating capacity. Therefore, product sequences and mature protein forms should be considered in experiments.

(3) Concentration and Time Gradients

Chemokine experiments should include both concentration and time gradients. A single high-concentration treatment can readily cause receptor desensitization and cannot provide a complete dose-response relationship.

(4) Endotoxin and Protein Stability

Neutrophils, monocytes, and macrophages are highly sensitive to endotoxin. The endotoxin level of recombinant proteins should be considered, and repeated freeze-thaw cycles or improper storage that may cause protein aggregation and reduced activity should be avoided.

 

Experimental Method

Main Detection Content

Key Indicators

Interpretation Considerations

Transwell migration assay

Endpoint cell migration

Number of migrated cells, migration rate, and chemotactic index

Include no-gradient and equal-concentration controls

Microfluidic chemotaxis assay

Dynamic migration in a stable gradient

Directionality, speed, and trajectory length

Distinguish chemotaxis from increased random motility

Ca²⁺-flux assay

Early receptor activation

Fluorescence peak and duration

Increased Ca²⁺ alone does not prove migration

Receptor-internalization assay

Receptor activation and desensitization

Changes in cell-surface receptor levels

Degree of internalization does not necessarily equal chemotactic strength

Downstream-signaling assay

PI3K, AKT, ERK, p38, and related signals

Phosphorylation levels and temporal changes

Include receptor blockade and time-course analysis

Receptor knockdown or knockout

Receptor dependence

Degree of reduction in migration and signaling

Exclude compensation by other receptors

Flow-based adhesion assay

Leukocyte adhesion and transendothelial migration

Rolling, arrest, firm adhesion, and transmigration counts

Results are affected by shear stress and endothelial status

 

6 Products

6.1 CXC Chemokine Products Related to Neutrophil Recruitment

 

Catalog #

Name

Grade & Purity

Major Receptor or Functional Axis

Main Research Application

rp183578

Recombinant Mouse CXCL1/KC Protein

Carrier-free, PBS Only, ≥95% (SDS-PAGE)

CXCR2

Mouse neutrophil migration, acute inflammation, and CXCR2-function research

rp168795

Recombinant Mouse CXCL1/KC Protein

Animal Free, carrier-free, Bioactive, ActiBioPure™, azide-free, high performance, PBS Only, ≥97% (SDS-PAGE and HPLC)

CXCR2

Mouse neutrophil chemotaxis, inflammatory-cell recruitment, and CXCR2-signaling research

rp329917

Recombinant Mouse CXCL1 Protein

≥90% (SDS-PAGE)

CXCR2

Mouse CXCL1 dose-response, cell-migration, and receptor-blocking research

rp170437

Recombinant Human CXCL1/GRO alpha Protein

Carrier-free, PBS Only, ≥90% (SDS-PAGE), see COA

CXCR2

Human neutrophil migration, acute inflammation, and recruitment of tumor-associated myeloid cells

rp183581

Recombinant Mouse CXCL2 Protein

Carrier-free, PBS Only, ≥90% (SDS-PAGE)

CXCR2

Mouse infection, tissue injury, and neutrophil-recruitment research

rp179803

Recombinant Human CXCL2/GRO beta Protein

Carrier-free, PBS Only, ≥90% (SDS-PAGE)

CXCR2

Human neutrophil chemotaxis and comparative functional research on CXCL1 and CXCL2

rp146664

Recombinant Human GRO Gamma Protein

Animal Free, carrier-free, Bioactive, ActiBioPure™, azide-free, high performance, PBS Only, ≥97% (SDS-PAGE and HPLC)

CXCR2

Human CXCL3/GROγ-mediated neutrophil migration and CXCR2-signaling research

rp181572

Recombinant Human CXCL3/GRO gamma Protein

Carrier-free, PBS Only, ≥95% (SDS-PAGE), see COA

CXCR2

Comparative analysis of CXCL1, CXCL2, and CXCL3 chemotactic activity and receptor responses

rp144864

Recombinant Human CXCL5 Protein

Animal Free, carrier-free, Bioactive, ActiBioPure™, azide-free, high performance, PBS Only, ≥97% (SDS-PAGE and HPLC)

CXCR2

CXCL5-CXCR2 axis, neutrophil recruitment, and inflammatory-microenvironment research

rp184094

Recombinant Human CXCL5/ENA-70 Protein

Carrier-free, PBS Only, ≥95% (SDS-PAGE), see COA

CXCR2

Human CXCL5 chemotactic activity and CXCR2-dependence research

rp173793

CXCL6

Moligand™

CXCR1 and CXCR2

Neutrophil migration, CXCR1 and CXCR2 receptor selectivity, and signaling research

rp329850

Recombinant Mouse CXCL7 Protein

≥90% (SDS-PAGE)

CXCR2-associated axis

Mouse CXCL7 function, platelet-associated inflammation, and neutrophil-migration research

rp144868

Recombinant Human CXCL7/PBP Protein

Animal Free, carrier-free, Bioactive, ActiBioPure™, azide-free, high performance, PBS Only, ≥97% (SDS-PAGE and HPLC)

CXCL7 processing and CXCR2-associated axis

CXCL7 precursor processing, platelet-derived chemokines, and comparison of mature forms

rp181578

Recombinant Human CXCL7/NAP-2 Protein

Carrier-free, PBS Only, ≥90% (SDS-PAGE), see COA

CXCR2

Neutrophil migration, degranulation, and platelet-derived inflammatory-signaling research

rp186593

Recombinant Porcine IL-8/CXCL8 Protein

Carrier-free, PBS Only, ≥95% (SDS-PAGE)

CXCR1 and CXCR2

Porcine neutrophil migration, infection-associated inflammation, and CXCL8-receptor research

rp192261

Recombinant Porcine IL-8/CXCL8 Protein

Carrier-free, His tag, SUMO tag, PBS Only, ≥90% (SDS-PAGE)

CXCR1 and CXCR2

Porcine-cell chemotaxis and CXCL8-signaling research

 

6.2 CXCL4, CXCR3 Ligands, and Tissue-Positioning-Related CXC Chemokine Products

 

Catalog #

Name

Grade & Purity

Major Receptor or Functional Axis

Main Research Application

rp170411

Recombinant Human CXCL4/PF4 Protein

Carrier-free, Bioactive, ActiBioPure™, His tag, ≥95% (SDS-PAGE), see COA

Glycosaminoglycan binding and cell-type-dependent signaling

Human platelet-associated inflammation, monocyte regulation, vascular injury, and CXCL4-complex research

rp329522

Recombinant Rat PF4 Protein

≥90% (SDS-PAGE)

CXCL4-associated signaling

Rat platelet activation, vascular injury, and thromboinflammation research

rp329513

Recombinant Mouse PF4 Protein

≥90% (SDS-PAGE)

CXCL4-associated signaling

Mouse platelet-associated inflammation, monocyte regulation, and CXCL4-function research

rp144872

Recombinant Human CXCL9 Protein

Animal Free, carrier-free, Bioactive, ActiBioPure™, azide-free, high performance, ≥97% (SDS-PAGE and HPLC)

CXCR3

Migration of human activated T cells and NK cells, Th1-type immunity, and tumor-immunity research

rp170398

Recombinant Human CXCL9/MIG Protein

Carrier-free, Bioactive, ActiBioPure™, high performance, PBS Only, ≥95% (SDS-PAGE)

CXCR3

CXCR3 activation, effector-lymphocyte recruitment, and interferon-associated inflammation research

rp183583

Recombinant Mouse CXCL9/MIG Protein

Carrier-free, Bioactive, ActiBioPure™, high performance, His tag, MBP tag, ≥95% (SDS-PAGE), expressed in E. coli, see COA

CXCR3

Mouse T-cell migration, infection-associated inflammation, and tumor-immunity model research

rp170434

Recombinant Human CXCL10/IP-10 Protein

Carrier-free, Bioactive, ActiBioPure™, PBS Only, ≥90% (SDS-PAGE)

CXCR3

Human T-cell and NK-cell chemotaxis, antiviral immunity, and tumor-immunity research

rp153848

Recombinant Mouse CXCL10/IP-10 Protein

Animal Free, carrier-free, Bioactive, ActiBioPure™, azide-free, high performance, PBS Only, ≥97% (SDS-PAGE and HPLC)

CXCR3

Mouse interferon responses, lymphocyte infiltration, and inflammatory-model research

rp173761

CXCL11

Moligand™

CXCR3

CXCR3 ligand-biased signaling, receptor internalization, and T-cell migration research

rp179844

Recombinant Human/Rhesus Macaque/Feline CXCL12/SDF-1 alpha Protein

Carrier-free, ≥95% (SDS-PAGE), expressed in E. coli, see COA

CXCR4 and ACKR3

Hematopoietic-cell homing, CXCR4 signaling, cell migration, and cross-species functional research

rp153852

Recombinant Mouse CXCL16 Protein

Animal Free, carrier-free, Bioactive, ActiBioPure™, azide-free, high performance, PBS Only, ≥98% (SDS-PAGE and HPLC)

CXCR6

Migration of mouse CXCR6-positive T cells and NK cells and tissue-inflammation research

rp144853

Recombinant Human CXCL16 Protein

Animal Free, carrier-free, Bioactive, ActiBioPure™, high performance, His tag, ≥95% (SDS-PAGE)

CXCR6

Human CXCL16-CXCR6 axis, lymphocyte migration, and vascular-inflammation research

rp184867

Recombinant Mouse CXCL17/VCC-1 Protein

Carrier-free, His tag, PBS Only, ≥90% (SDS-PAGE), see COA

Functional receptor not yet conclusively identified

Mouse mucosal immunity, monocyte migration, and CXCL17-receptor exploration research

 

6.3 CC Chemokine-Related Products

 

Catalog #

Name

Grade & Purity

Major Receptor or Functional Axis

Main Research Application

rp143723

Recombinant Human CCL1 Protein

Animal Free, carrier-free, Bioactive, ActiBioPure™, azide-free, high performance, PBS Only, ≥97% (SDS-PAGE and HPLC)

CCR8

Human CCL1-CCR8 axis, regulatory T-cell migration, and tumor-immunity research

rp153679

Recombinant Mouse CCL1/TCA-3 Protein

Animal Free, carrier-free, recombinant, ActiBioPure™, high performance, His tag, Fc tag, ≥95% (SDS-PAGE)

CCR8

Migration of mouse CCR8-positive cells, Th2-type immunity, and tissue immune-regulation research

rp170414

Recombinant Human CCL3/MIP-1 alpha Protein

Carrier-free, Bioactive, high performance, ≥90% (SDS-PAGE)

CCR1 and CCR5

Migration of monocytes, T cells, and other inflammatory cells and CCR1/CCR5-function research

rp329428

Recombinant Human CCL5/RANTES Protein

≥95% (SDS-PAGE)

CCR1, CCR3, and CCR5

Migration of T cells, monocytes, and eosinophils and chronic-inflammation research

rp148607

Recombinant Human CCL8/MCP-2 Protein

Animal Free, carrier-free, Bioactive, ActiBioPure™, azide-free, high performance, PBS Only, ≥96% (SDS-PAGE and HPLC)

CCR1, CCR2, CCR3, and CCR5

Migration of monocytes, T cells, and eosinophils and receptor-selectivity research

rp181315

Recombinant Human CCL8/MCP-2 Protein

Carrier-free, Bioactive, ActiBioPure™, high performance, ≥95% (SDS-PAGE)

CCR1, CCR2, CCR3, and CCR5

Human CCL8 dose-response, receptor blockade, and inflammatory-cell recruitment research

rp148478

Recombinant Human CCL15 Protein

Animal Free, carrier-free, Bioactive, ActiBioPure™, azide-free, high performance, PBS Only, ≥97% (SDS-PAGE and HPLC)

CCR1 and CCR3

Monocyte and myeloid-cell migration, CCL15 processing, and receptor-function research

rp183663

Recombinant Human CCL15/MIP-5 Protein

Carrier-free, Bioactive, ActiBioPure™, high performance, ≥95% (SDS-PAGE), see COA

CCR1 and CCR3

CCL15-CCR1 axis, chronic inflammation, and myeloid-cell recruitment research

rp152075

Recombinant Human TARC/CCL17 Protein

Animal Free, carrier-free, Bioactive, ActiBioPure™, azide-free, high performance, PBS Only, ≥97% (SDS-PAGE and HPLC)

CCR4

Migration of Th2 cells and certain regulatory T cells, allergic inflammation, and tumor-immunity research

rp170428

Recombinant Human CCL17/TARC Protein

Carrier-free, ≥95% (SDS-PAGE)

CCR4

CCL17-CCR4 axis, skin inflammation, and chemotaxis of CCR4-positive T cells

 

Chemokine research requires simultaneous consideration of ligand species, receptor expression, spatial gradients, and mature protein forms. Migration assays, receptor blockade, and appropriate no-gradient controls allow more accurate determination of the actual effects of specific chemokine-receptor axes on immune-cell recruitment.

目录: 技术文章

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Classification of Chemokines, Receptor Signaling, and Regulatory Mechanisms of Immune Cell Migration》. 阿拉丁知识库,更新于 2026年8月26日。 https://www.aladdin-e.com/zh_cn/faqs/classification-of-chemokines-receptor-signaling-and-regulatory-mechanisms-of-immune-cell-migration-en.html
这篇文章对您有帮助吗? Yes No 有 1 人觉得有帮助